.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Citi
Johnson and Johnson
QuintilesIMS
Cipla
Chinese Patent Office
Deloitte
McKesson
Daiichi Sankyo
Cerilliant

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020355

« Back to Dashboard

NDA 020355 describes STIMATE (NEEDS NO REFRIGERATION), which is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. Additional details are available on the STIMATE (NEEDS NO REFRIGERATION) profile page.

The generic ingredient in STIMATE (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Summary for 020355

Tradename:2
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020355

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STIMATE desmopressin acetate SPRAY, METERED;NASAL 020355 NDA CSL Behring LLC 0053-6871 0053-6871-00 1 BOTTLE, SPRAY in 1 CARTON (0053-6871-00) > 2.5 mL in 1 BOTTLE, SPRAY
STIMATE (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 020355 NDA CSL Behring LLC 0053-6871 0053-6871-00 1 BOTTLE, SPRAY in 1 CARTON (0053-6871-00) > 2.5 mL in 1 BOTTLE, SPRAY

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.15MG/SPRAY
Approval Date:Mar 7, 1994TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;NASALStrength0.15MG/SPRAY
Approval Date:Oct 24, 2007TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Citi
Teva
Accenture
Chinese Patent Office
Baxter
Boehringer Ingelheim
Dow
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot